Thursday, August 17, 2017 8:33:56 PM
I emailed the ceo yesterday about phase II and the following was his response:
"Rick,
We have already finalized the IND filing and the protocol. We need some funding to move into Phase II. We are working with outside funders that can move this forward without diluting Nutra Pharma. We expect to finalize everything in the next 60 days with the goal to begin the trial before the end of the year. Of course, we will announce milestones as they occur.
Yours truly,
Rik"
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM
Avant Technologies to Implement AI-Empowered, Zero Trust Architecture in Its Data Centers • AVAI • Apr 29, 2024 8:00 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM